Error: Could not add to watchlist. X

BB Adamant Global Generika

+ Watchlist
ADGN:SW
SIX Swiss Ex
1,409.00
CHF
35.00
2.42%
As of 11:31:59 ET on 02/05/2016.
Open
1,409.00
Day Range
1,476.00 - 1,492.00
Previous Close
1,444.00
52Wk Range
1,429.00 - 1,798.00
1 Yr Return
-10.54%
YTD Return
-9.39%
Open
1,409.00
Day Range
1,476.00 - 1,492.00
Volume
0
Previous Close
1,444.00
52Wk Range
1,429.00 - 1,798.00
1 Yr Return
-10.20%
YTD Return
-9.39%
NAV (on -)
-
Total Assets (m CHF) (on 02/04/2016)
161.400
Inception Date
-
Premium/Discount
-
Average 52-Week Premium
-
Fund Managers
OLIVER KUBLI
Last Dividend (on 12/03/2015)
-
Dividend Indicated Gross Yield
-
Expense Ratio
1.83%
3 Mo Return
-10.48%
3 Yr Return
-
5 Yr Return
-
Top Fund Holdings
Name Position Value % of Fund
Allergan plc 30.00 k 9.12 m 5.16
Sawai Pharmaceutical Co Ltd 130.00 k 8.25 m 4.67
Lonza Group AG 50.00 k 7.26 m 4.11
Express Scripts Holding Co 80.00 k 6.81 m 3.86
Dr Reddy's Laboratories Ltd 100.00 k 6.39 m 3.62
Medy-Tox Inc 15.00 k 6.32 m 3.58
Coherus Biosciences Inc 230.00 k 6.31 m 3.57
Yuhan Corp 25.00 k 6.12 m 3.46
Endo International PLC 100.00 k 5.91 m 3.35
Teva Pharmaceutical Industries 100.00 k 5.83 m 3.30
Profile
BB Adamant Global Generika Fund is an open-ended investment company incorporated in Switzerland. The Fund's aim is to generate long-term capital growth through active management by investing in companies within the generic sector. The Fund's portfolio will be concentarted to around 30 to 50 stocks which fully meet Adamant's strict selection criteria.
ADDRESS
Balfidor Fondsleitung AG
Peter-Merian Strasse 47
CH 4002 Basel
Switzerland
PHONE
+41 800 850 050